CK Biotech (CK Regeon)

Category:
Main Business Area

CK Biotech, also known as CK Regeon, is a global biotech startup leading the development of neuroprotective and therapeutic agents against neuronal disorders. They have successfully obtained FDA orphan drug designation for their autism treatment candidate (NV01-A02) and are currently preparing for phase 2 clinical trials in Korea.

Wishlist
Contact Details

#B137 Yonsei Engineering Research Park, Yonsei University, Yonsei-ro 50, Seodaemoon-gu, Seoul 02-364-6585ckr@ckregeon.com

Find out more companies
Scroll to Top